Related references
Note: Only part of the references are listed.Neuroprotective Function of 14-3-3 Proteins in Neurodegeneration
Tadayuki Shimada et al.
BIOMED RESEARCH INTERNATIONAL (2013)
A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease
Clive Hamlin et al.
NEUROLOGY (2012)
High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease
Yuki Matsui et al.
BMC NEUROLOGY (2011)
Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
Gianluigi Zanusso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Elevated Levels of Tau Protein in Cerebrospinal Fluid of Patients With Probable Creutzfeldt-Jakob Disease
Gui-Rong Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation
Golam Sadik et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease
Justyna Maria Czarna Bahl et al.
NEUROBIOLOGY OF AGING (2009)
14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes
K. Gmitterova et al.
NEUROBIOLOGY OF AGING (2009)
Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease
Katsuya Satoh et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Detection of CSF 14-3-3 protein in Guillain-Barre syndrome
A. Bersano et al.
NEUROLOGY (2006)
14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan
K Satoh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2006)
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease
K Buerger et al.
NEUROBIOLOGY OF AGING (2006)
Phosphorylated 14-3-3ξ protein in the CSF of neuroleptic-treated patients
G Zanusso et al.
NEUROLOGY (2005)
Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
L Cepek et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease
RJ Castellani et al.
NEUROLOGY (2004)
Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes
C Mackintosh
BIOCHEMICAL JOURNAL (2004)
A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease
B Van Everbroeck et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease
MD Geschwind et al.
ARCHIVES OF NEUROLOGY (2003)
14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex
A Agarwal-Mawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias
M Riemenschneider et al.
MOLECULAR PSYCHIATRY (2003)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
14-3-3 protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease
R Sanchez-Valle et al.
NEUROSCIENCE LETTERS (2002)
Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease
T Chapman et al.
NEUROLOGY (2000)
Share Paper
